Cormorant Asset Management, LP - FORWARD PHARMA A/S ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of FORWARD PHARMA A/S
ValueSharesWeighting
Q1 2017$12,697,000
+149.4%
589,175
+73.7%
1.84%
+168.8%
Q4 2016$5,091,000
-28.5%
339,1750.0%0.69%
-12.6%
Q3 2016$7,123,000
+15.6%
339,1750.0%0.78%
-10.2%
Q2 2016$6,163,000
+8.2%
339,175
+1.2%
0.87%
+1.9%
Q1 2016$5,696,000
-10.5%
335,0680.0%0.86%
+12.6%
Q4 2015$6,366,000
-19.4%
335,0680.0%0.76%
-39.6%
Q3 2015$7,894,000
-18.6%
335,068
+31.4%
1.26%
-2.2%
Q2 2015$9,703,000
+34.4%
255,0000.0%1.29%
+15.6%
Q1 2015$7,222,000
+131.1%
255,000
+70.0%
1.12%
+131.5%
Q4 2014$3,125,000150,0000.48%
Other shareholders
FORWARD PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 1,455,117$8,571,0001.09%
Baupost Group 6,463,265$39,232,0000.49%
Newtyn Management, LLC 268,903$1,584,0000.26%
Assured Investment Management LLC 1,475,612$7,383,0000.15%
Freedom Investment Management, Inc. 76,867$467,0000.03%
NJ State Employees Deferred Compensation Plan 10,000$59,0000.01%
TWO SIGMA SECURITIES, LLC 14,331$84,0000.01%
HIGHLAND CAPITAL MANAGEMENT LP 17,000$100,0000.00%
ALPS ADVISORS INC 46,468$274,0000.00%
Renaissance Technologies 181,900$1,104,0000.00%
View complete list of FORWARD PHARMA A/S shareholders